Table of Contents

1. Introduction

1.1 Market Definition

1.2 Scope

1.3 Research Assumptions

2. Research Methodology

3. Market Dynamics

3.1 Drivers           

3.2 Restraints

3.3 Opportunities

3.4 Challenges

4. Impact Analysis

4.1 COVID-19 Impact Analysis

4.2 Impact of Ukraine- Russia war

4.3 Impact of ongoing Recession

4.3.1 Introduction

4.3.2 Impact on major economies

4.3.2.1 US

4.3.2.2 Canada

4.3.2.3 Germany

4.3.2.4 France

4.3.2.5 United Kingdom

4.3.2.6 China

4.3.2.7 Japan

4.3.2.8 South Korea

4.3.2.9 Rest of the World

5. Value chain analysis

6. Porter’s 5 forces model

7. PEST analysis

8. Global Glucosamine Market segmentation, By Product Type:

8.1 Powder

8.2 Tablets

8.3 Capsules

8.4 Liquid

9. Global Glucosamine Market segmentation, By Application:

9.1 Rheumatoid Arthritis

9.2 Asthma

9.3 Inflammatory Bowel Disease

9.4 Others

10. Global Glucosamine Market, by region/ country

10.1 Introduction

10.2 North America

10.2.1 USA

10.2.2 Canada

10.2.3 Mexico

10.3 Europe

10.3.1 Germany

10.3.2 UK

10.3.3 France

10.3.4 Italy

10.3.5 Spain

10.3.6 The Netherlands

10.3.7 Rest of Europe

10.4 Asia-Pacific

10.4.1 Japan

10.4.2 South Korea

10.4.3 China

10.4.4 India

10.4.5 Australia

10.4.6 Rest of Asia-Pacific

10.5 The Middle East & Africa

10.5.1 Israel

10.5.2 UAE

10.5.3 South Africa

10.5.4 Rest

10.6 Latin America

10.6.1 Brazil

10.6.2 Argentina

10.6.3 Rest of Latin America

11. Company profiles

11.1 Bio-gen Extracts Private Limited

11.1.1 Financial

11.1.2 Products/ Services Offered

11.1.3 Swot Analysis

11.1.4 The SNS View

11.2 Panvo Organics Pvt Ltd

11.3 Pharma Base S.A.

11.4 CAPTEK Softgel International Inc.

11.5 TSI GROUP LTD

11.6 Cargill, Incorporated

11.7 CELLMARK AB.

11.8 Zhejiang Zhoushan Putuo Xinxing Pharmas Co., Ltd.  (PXPC)

11.9 Andra Medi Pharma Pvt. Ltd

11.10 Jiaxing Hengjie Biopharmaceutical Co., Ltd.

12. Competitive Landscape

12.1 Competitive Bench Marking

12.2 Market Share Analysis

12.3 Recent Developments

13. Conclusion